These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38034009)

  • 1. A molecular signature for the G6PC3/SLC37A2/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype.
    Torabidastgerdooei S; Roy ME; Annabi B
    Front Endocrinol (Lausanne); 2023; 14():1265698. PubMed ID: 38034009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
    Chou JY; Jun HS; Mansfield BC
    J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
    Pan CJ; Chen SY; Jun HS; Lin SR; Mansfield BC; Chou JY
    PLoS One; 2011; 6(9):e23157. PubMed ID: 21949678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SLC37 family of sugar-phosphate/phosphate exchangers.
    Chou JY; Mansfield BC
    Curr Top Membr; 2014; 73():357-82. PubMed ID: 24745989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SLC37 family of phosphate-linked sugar phosphate antiporters.
    Chou JY; Sik Jun H; Mansfield BC
    Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.
    Cappello AR; Curcio R; Lappano R; Maggiolini M; Dolce V
    Front Chem; 2018; 6():122. PubMed ID: 29719821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma.
    Iwadate Y; Matsutani T; Hirono S; Shinozaki N; Saeki N
    J Neurooncol; 2016 Aug; 129(1):101-7. PubMed ID: 27193555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.
    Veiga-da-Cunha M; Chevalier N; Stephenne X; Defour JP; Paczia N; Ferster A; Achouri Y; Dewulf JP; Linster CL; Bommer GT; Van Schaftingen E
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1241-1250. PubMed ID: 30626647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.
    Abbadi S; Rodarte JJ; Abutaleb A; Lavell E; Smith CL; Ruff W; Schiller J; Olivi A; Levchenko A; Guerrero-Cazares H; Quinones-Hinojosa A
    Mol Cancer Res; 2014 Nov; 12(11):1547-59. PubMed ID: 25001192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells.
    Roy ME; Veilleux C; Paquin A; Gagnon A; Annabi B
    Anticancer Drugs; 2024 Sep; 35(8):709-719. PubMed ID: 38900643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
    Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
    Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β mimics the key proteome properties of CD133
    Bryukhovetskiy I; Shevchenko V; Arnotskaya N; Kushnir T; Pak O; Victor Z; Zaitsev S; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS
    Int Rev Neurobiol; 2020; 151():219-242. PubMed ID: 32448609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
    Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
    Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency.
    Hiwarkar P; Bargir U; Pandrowala A; Bodhanwala M; Thakker N; Taur P; Madkaikar M; Desai M
    J Clin Immunol; 2022 Nov; 42(8):1653-1659. PubMed ID: 35838821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Translational Regulation of the Glucose-6-Phosphatase Complex by Cyclic Adenosine Monophosphate Is a Crucial Determinant of Endogenous Glucose Production and Is Controlled by the Glucose-6-Phosphate Transporter.
    Soty M; Chilloux J; Delalande F; Zitoun C; Bertile F; Mithieux G; Gautier-Stein A
    J Proteome Res; 2016 Apr; 15(4):1342-9. PubMed ID: 26958868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres.
    Gresseau L; Roy ME; Duhamel S; Annabi B
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497426
    [No Abstract]   [Full Text] [Related]  

  • 19. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
    Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
    Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.
    Boulanger C; Stephenne X; Diederich J; Mounkoro P; Chevalier N; Ferster A; Van Schaftingen E; Veiga-da-Cunha M
    J Inherit Metab Dis; 2022 Jul; 45(4):759-768. PubMed ID: 35506446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.